Medica Sur SA de CV Class B (MEDICAB) Ratios
Medica Sur SA de CV Class B Ratios
MX:MEDICAB's free cash flow for Q2 2026 was $0.00. For the 2026 fiscal year, MX:MEDICAB's free cash flow was increased by $62.45M and operating cash flow was $-62.45M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.60 | 0.78 | 1.22 | 1.69 | 4.12 |
| Quick Ratio | 1.51 | 0.72 | 1.09 | 1.55 | 3.99 |
| Cash Ratio | 1.30 | 0.56 | 0.68 | 1.22 | 3.52 |
| Solvency Ratio | 0.33 | 0.32 | 0.39 | 0.54 | 0.64 |
| Operating Cash Flow Ratio | 0.82 | 0.30 | 0.41 | 0.27 | 0.82 |
| Short-Term Operating Cash Flow Coverage | 8008.17 | 0.58 | 21.83 | 13.64 | 42.30 |
| Net Current Asset Value | $ -354.14M | $ -509.03M | $ -818.77M | $ -369.07M | $ 2.06B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.21 | 0.24 | 0.25 | 0.23 | 0.15 |
| Debt-to-Equity Ratio | 0.40 | 0.45 | 0.51 | 0.42 | 0.22 |
| Debt-to-Capital Ratio | 0.29 | 0.31 | 0.34 | 0.29 | 0.18 |
| Long-Term Debt-to-Capital Ratio | 0.28 | 0.00 | 0.33 | 0.28 | 0.17 |
| Financial Leverage Ratio | 1.89 | 1.88 | 2.03 | 1.82 | 1.42 |
| Debt Service Coverage Ratio | 7.96 | 0.63 | 8.56 | 7.50 | 8.49 |
| Interest Coverage Ratio | 7.56 | 7.52 | 9.65 | 9.95 | 10.40 |
| Debt to Market Cap | 0.15 | 0.28 | 0.23 | 0.25 | 0.17 |
| Interest Debt Per Share | 10.36 | 10.44 | 10.44 | 10.48 | 9.37 |
| Net Debt to EBITDA | -0.48 | -0.09 | 0.35 | -0.18 | -2.24 |
| Profitability Margins | |||||
| Gross Profit Margin | 35.84% | 33.88% | 35.34% | 35.35% | 39.30% |
| EBIT Margin | 18.96% | 15.21% | 19.78% | 19.48% | 17.67% |
| EBITDA Margin | 23.13% | 19.62% | 24.11% | 23.86% | 28.09% |
| Operating Profit Margin | 16.76% | 12.90% | 17.61% | 19.54% | 20.99% |
| Pretax Profit Margin | 16.74% | 13.49% | 17.96% | 17.52% | 16.38% |
| Net Profit Margin | 11.28% | 10.48% | 15.38% | 24.56% | 29.56% |
| Continuous Operations Profit Margin | 11.28% | 9.60% | 13.51% | 12.22% | 9.15% |
| Net Income Per EBT | 67.39% | 77.68% | 85.63% | 140.18% | 180.45% |
| EBT Per EBIT | 99.91% | 104.57% | 101.93% | 89.64% | 78.04% |
| Return on Assets (ROA) | 11.31% | 10.46% | 15.38% | 20.75% | 16.53% |
| Return on Equity (ROE) | 21.42% | 19.70% | 31.18% | 37.67% | 23.50% |
| Return on Capital Employed (ROCE) | 22.36% | 23.58% | 23.55% | 21.12% | 13.71% |
| Return on Invested Capital (ROIC) | 15.03% | 11.74% | 17.49% | 14.61% | 8.00% |
| Return on Tangible Assets | 11.66% | 10.81% | 15.86% | 21.33% | 16.83% |
| Earnings Yield | 8.33% | 12.65% | 14.39% | 23.65% | 19.23% |
| Efficiency Ratios | |||||
| Receivables Turnover | 20.71 | 16.07 | 10.20 | 12.50 | 8.55 |
| Payables Turnover | 11.04 | 10.71 | 9.68 | 8.91 | 8.81 |
| Inventory Turnover | 30.55 | 25.84 | 19.26 | 18.46 | 18.70 |
| Fixed Asset Turnover | 2.02 | 1.85 | 1.72 | 1.55 | 1.51 |
| Asset Turnover | 1.00 | 1.00 | 1.00 | 0.85 | 0.56 |
| Working Capital Turnover Ratio | 35.84 | -41.69 | 8.97 | 2.03 | 2.06 |
| Cash Conversion Cycle | -3.49 | 2.75 | 17.06 | 7.98 | 20.75 |
| Days of Sales Outstanding | 17.63 | 22.71 | 35.80 | 29.19 | 42.67 |
| Days of Inventory Outstanding | 11.95 | 14.13 | 18.95 | 19.77 | 19.52 |
| Days of Payables Outstanding | 33.06 | 34.09 | 37.69 | 40.98 | 41.43 |
| Operating Cycle | 29.57 | 36.84 | 54.75 | 48.96 | 62.19 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 8.97 | 5.54 | 3.94 | 2.50 | 6.66 |
| Free Cash Flow Per Share | 7.43 | 4.27 | 1.95 | 0.77 | 5.44 |
| Dividend Paid and CapEx Coverage Ratio | 3.09 | 2.07 | 0.49 | 0.08 | 2.63 |
| Capital Expenditure Coverage Ratio | 5.83 | 4.36 | 1.98 | 1.45 | 5.45 |
| Operating Cash Flow Coverage Ratio | 0.96 | 0.57 | 0.40 | 0.26 | 0.76 |
| Operating Cash Flow to Sales Ratio | 0.20 | 0.14 | 0.10 | 0.07 | 0.21 |
| Free Cash Flow Yield | 12.38% | 12.56% | 4.76% | 2.08% | 11.17% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 12.00 | 7.91 | 6.95 | 4.23 | 5.20 |
| Price-to-Sales (P/S) Ratio | 1.35 | 0.83 | 1.07 | 1.04 | 1.54 |
| Price-to-Book (P/B) Ratio | 2.57 | 1.56 | 2.17 | 1.59 | 1.22 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 8.08 | 7.96 | 20.99 | 48.01 | 8.95 |
| Price-to-Operating Cash Flow Ratio | 6.69 | 6.13 | 10.41 | 14.87 | 7.31 |
| Price-to-Earnings Growth (PEG) Ratio | 0.74 | -0.29 | -0.21 | -0.71 | 0.05 |
| Enterprise Value Multiple | 5.37 | 4.13 | 4.78 | 4.17 | 3.23 |
| Enterprise Value | 5.95B | 3.57B | 4.76B | 3.85B | 3.55B |
| EV to EBITDA | 5.37 | 4.13 | 4.78 | 4.17 | 3.23 |
| EV to Sales | 1.24 | 0.81 | 1.15 | 1.00 | 0.91 |
| EV to Free Cash Flow | 7.41 | 7.79 | 22.62 | 46.02 | 5.29 |
| EV to Operating Cash Flow | 6.14 | 6.00 | 11.22 | 14.25 | 4.32 |
| Tangible Book Value Per Share | 22.02 | 20.53 | 17.78 | 22.22 | 38.86 |
| Shareholders’ Equity Per Share | 23.34 | 21.83 | 18.92 | 23.36 | 39.85 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.33 | 0.29 | 0.25 | 0.30 | 0.41 |
| Revenue Per Share | 44.32 | 41.02 | 38.37 | 35.83 | 31.68 |
| Net Income Per Share | 5.00 | 4.30 | 5.90 | 8.80 | 9.36 |
| Tax Burden | 0.67 | 0.78 | 0.86 | 1.40 | 1.80 |
| Interest Burden | 0.88 | 0.89 | 0.91 | 0.90 | 0.93 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.20 | 0.19 | 0.21 | 0.10 | 0.09 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.79 | 1.29 | 0.67 | 0.28 | 0.71 |
Currency in MXN